How AI Fixes Broken Clinical Trials & Empowers Cancer Patients - Adam Blum

Why do only 3% ofcancer patients ever access clinical trials when advanced trials oftenrepresent superior care, and how is generative AI solving the unstructured datacrisis that prevents patients from accessing life-saving treatments? Adam Blum is a veteran technologist, softwarearchitect, cancer survivor, and the founder of CancerBot—anon-profit AI platform designed to make precision clinical trial matchingaccessible and free for everyone. While on an intense cycling expedition acrossthe French Alps, Adam experienced sudden, debilitating exhaustion, culminatingin an unexpected diagnosis of follicular lymphoma. When he asked his oncologistabout cutting-edge clinical trials, his doctor lacked the hundreds of hoursrequired to dig through clinical trial registers. Refusing to settle forstandard of care without exploring every option, Adam spent weeks manuallyparsing dense, unstructured eligibility text across global registries.Recognizing that traditional commercial search tools fail because they onlycheck basic demographic tags, Adam engineered CancerBot using Large LanguageModels to convert narrative eligibility protocols into a queryable, structureddatabase. In this episode of FailCraft, Adamjoins Ezekiel to demonstrate live matching for cutting-edge therapies(including bispecific antibodies like Epcoritamab and CAR-T), discuss thepsychological toll of diagnosis, expose why delayed trials stall global medicalscience, and explain why taking active agency over your medical data is thegreatest predictor of survival. Key Takeaways:                Connect With Adam Blum &CancerBot:    Support the Show:    Want to Be a Guest onFailCraft?  Chapters: 00:00 Introduction:Adam Blum & The Clinical Trial Crisis 01:50 The DatabaseBarrier: Why Oncologists Can't Read Hundreds of Protocols 03:52 BeyondDemographics: The Need for Precision Patient Matching 05:03 The AlpsInterruption: Follicular Lymphoma & The Reality of Bone-Deep Fatigue 06:15 The 3% Dilemma:Why Revolutionary Therapies Get Delayed for Years 08:35 AdvancedImmunology: Bispecific Antibodies, Epcoritamab & CAR-T 11:12 InsideCancerBot: Live Screening, Prior Lines of Therapy & Matching Scores 15:41 The AIChallenge: Turning Unstructured Text into Patent-Worthy Data 18:30 First StepsTomorrow: Taking Agency & Becoming an Educated Patient 21:46 RedefiningSuccess: Harmonizing Health Records & Empowering Patients 24:09 Connect withAdam Blum at CancerBot.org